Dr. Anthony Ovekunle CML Chronic Myeloid Leukemia
Dr.Anthony Ovekunkle is Hematologist with special interest in hematologic malignancies, hematopoietic stem cell transplantation, chronic myeloid leukemia and molecular diagnostics.
University of Botswana and Princess Marina Hospital Gaborone, Botswana Andreas
See more about Dr Ovekunkle
ARTICLES
A decision trees-based classification model for the survival of chronic myeloid leukemia (CML) patients
October 2016, Obafemi Awolowo University, Ile-Ife, Nigeria
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
June 2016. Clinical Medicine Insights: Blood Disorders
Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
October 2015, Advances in Hematology
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
December 2012, Annals of Hematology
A decision trees-based classification model for the survival of chronic myeloid leukemia (CML) patients
October 2016, Obafemi Awolowo University, Ile-Ife, Nigeria
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
June 2016. Clinical Medicine Insights: Blood Disorders
Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
October 2015, Advances in Hematology
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
December 2012, Annals of Hematology